Haleon (HLN) Intangibles (2021 - 2025)
Haleon (HLN) posted Intangibles of $34.1 billion for Q4 2025, up 1.27% on a QoQ basis from $33.6 billion in Q4 2024, and up 1.27% year-over-year from $33.6 billion in Q4 2024.
Haleon (HLN) Intangibles (2021 - 2025) Analysis & Trends
Haleon's Intangibles history runs 5 years deep, the most recent figure standing at $34.1 billion for Q4 2025.
- Quarterly Intangibles rose 1.27% year-over-year to $34.1 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $34.1 billion (up 1.27% YoY) and the FY2025 annual result came in at $33.8 billion, up 0.79% from the prior year.
- Intangibles was $34.1 billion for Q4 2025 at Haleon, up from $33.6 billion in the prior quarter.
- Across five years, Intangibles topped out at $35.9 billion in Q2 2022 and bottomed at -$261.9 million in Q4 2023.
- A 5-year average of $21.6 billion and a median of $33.5 billion in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2023 — Intangibles sank 133.13% — and 2024, when it soared 12946.14%.
- Haleon's Intangibles stood at $939.6 million in 2021, then decreased by 15.86% to $790.6 million in 2022, then sank by 133.13% to -$261.9 million in 2023, then surged by 12946.14% to $33.6 billion in 2024, then gained by 1.27% to $34.1 billion in 2025.
- Business Quant data shows HLN's Intangibles at $34.1 billion in Q4 2025, $33.6 billion in Q4 2024, and $33.3 billion in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 78.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.07 Bn |
| Dec 31, 2024 | 33.64 Bn |
| Jun 30, 2024 | 33.28 Bn |
| Dec 31, 2023 | -261.88 Mn |
| Jun 30, 2023 | 34.63 Bn |
| Dec 31, 2022 | 790.55 Mn |
| Jun 30, 2022 | 35.94 Bn |
| Dec 31, 2021 | 939.56 Mn |